Eltrombopag can interfere with lab tests

The TGA has issued a safety alert regarding the possibility of eltrombopag (Revolade) interfering with laboratory tests such as total bilirubin and creatinine. The thrombopoietin receptor (TPO-R) agonist can be hepatotoxic and the manufacturer advises monitoring of ALT, AST and bilirubin. Creatinine monitoring is also advised in patients with renal disease. However the highly coloured ...

Already a member?

Login to keep reading.

© 2021 the limbic